Beobachtungsplan, NIS 360: MARC – A Non-Interventional Multi-Country Study to Evaluate the Real-World Effectiveness of Avastin (Bevacizumab) for First-Line Treatment of Patients with Metastatic Colorectal Cancer and Known KRAS Status

Datei

• Artikel "Beobachtungsplan, NIS 360: MARC – A Non-Interventional Multi-Country Study to Evaluate the Real-World Effectiveness of Avastin (Bevacizumab) for First-Line Treatment of Patients with Metastatic Colorectal Cancer and Known KRAS Status"Herunterladen(PDF, 804KB, Datei ist nicht barrierefrei)